¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Help - - Sign up - Phone number 902 888 740
ISSN: 0301-0546

Allergologia et Immunopathologia

Founded in 1972 by Professor A. Oehling, Allergologia et Immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. Manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. Allergologia et Immunopathologia is the official journal of the Spanish Society of Pediatric Allergy and Clinical Immunology (SEICAP) and also of the Latin American Society of Immunodeficiencies (LASID). It has and independent international Editorial Committee which submits received papers for peer-reviewing by international experts. The journal accepts original and review articles from all over the world, together with consensus statements from the aforementioned societies. Occasionally, the opinion of an expert on a burning topic is published in the ¿Point of View¿ section. Letters to the Editor on previously published papers are welcomed. Allergologia et Immunopathologia publishes 6 issues per year and is included in the major databases such as Pubmed, Scopus, Web of Knowledge, etc.


  • Impact Factor: 1.689(2015)
  • 5-years Impact Factor: 1,456
  • SCImago Journal Rank (SJR):0,38
  • Source Normalized Impact per Paper (SNIP):0,591

© Thomson Reuters, Journal Citation Reports, 2015

Indexed in:

Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME Cancerlit, Bibliomed, CabHealth, Scisearch, HealthStar, Scopus, Prous, Science Intergews, Science Citation Index Expanded.
Contents of previous issue | Contents of following issue

Vol. 45. Num. 2. March - April 2017

Acknowledgment to reviewers

Allergol Immunopathol (Madr) 2017;45:vi

Original articles

Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma

I. Asher, T. Haahtela, O. Selroos, P. Ellwood, E. Ellwood
Allergol Immunopathol (Madr) 2017;45:105-14

The effect of nebulised magnesium sulphate in the management of childhood moderate asthma exacerbations as adjuvant treatment

S. Turker, M. Dogru, F. Yildiz, S. Bozkaya Yilmaz
Allergol Immunopathol (Madr) 2017;45:115-20

Comparison of two diagnostic techniques, skin-prick test and component resolved diagnosis in the follow-up of a cohort of paediatric patients with pollinosis. Multicentre pilot study in a highly exposed allergenic area

E. González-Mancebo, J. Domínguez-Ortega, S. Blanco-Bermejo, E. González-Seco, M.J. Trujillo, F. de la Torre
Allergol Immunopathol (Madr) 2017;45:121-6

Prevalence of oral allergy syndrome in children with allergic diseases

M. Bedolla-Barajas, A. Kestler-Gramajo, G. Alcalá-Padilla, J. Morales-Romero
Allergol Immunopathol (Madr) 2017;45:127-33

Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements

A. Giménez-Arnau, M. Ferrer, J. Bartra, I. Jáuregui, M. Labrador-Horrillo, J. Ortiz de Frutos, J.F. Silvestre, J. Sastre, M. Velasco, A. Valero
Allergol Immunopathol (Madr) 2017;45:134-44

Sleep disorders in Latin-American children with asthma and/or allergic rhinitis and normal controls

M. Urrutia-Pereira, D. Solé, H.J. Chong Neto, V. Acosta, A.M. Cepeda, M. Álvarez-Castelló, C.F. Almendarez, J. Lozano-Saenz, J.C. Sisul-Alvariza, N.A. Rosario, A.J. Castillo, M. Valentin-Rostan, H. Badellino, R.L. Castro-Almarales, M. González-León, C. Sanchez-Silot, M.M. Avalos, C. Fernandez, F. Berroa, M.M. De la Cruz, R.O.S. Sarni
Allergol Immunopathol (Madr) 2017;45:145-51

Uncovering potential key genes associated with the pathogenesis of asthma: A microarray analysis of asthma-relevant tissues

Y. Guan, X. Jin, X. Liu, Y. Huang, M. Wang
Allergol Immunopathol (Madr) 2017;45:152-9

The relation of innate and adaptive immunity with viral-induced acute asthma attacks: Focusing on IP-10 and cathelicidin

T. Arikoglu, E. Akyilmaz, D.D. Yildirim, S.B. Batmaz, S.T. Ulger, G. Aslan, S. Kuyucu
Allergol Immunopathol (Madr) 2017;45:160-8

Airway tone dysfunction among pre-schoolers with positive asthma predictive index: A case–control study

V. Lezana, A. Gajardo, L. Bofill, M. Gutierrez, S. Mora, J.A. Castro-Rodriguez
Allergol Immunopathol (Madr) 2017;45:169-74

Alternaria alternata acts on human Monocyte-derived Dendritic cells to mediate Th2/Th17 polarisation

A. Loghmani, R. Raoofi, A. Ownagh, N. Delirezh
Allergol Immunopathol (Madr) 2017;45:175-82

Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets

R. Yazdani, R. Seify, M. Ganjalikhani-Hakemi, H. Abolhassani, N. Eskandari, F. Golsaz-Shirazi, B. Ansaripour, E. Salehi, G. Azizi, N. Rezaei, A. Aghamohammadi
Allergol Immunopathol (Madr) 2017;45:183-92

Knowledge, perspectives and attitudes about allergen-specific immunotherapy for respiratory allergic disease among paediatricians in Turkey

S. Işık, A. Çağlar, B. Eroğlu-Filibeli, Ş. Çağlayan-Sözmen, Z. Arıkan-Ayyıldız, S. Asilsoy, N. Uzuner
Allergol Immunopathol (Madr) 2017;45:193-7

Safety of immunotherapy with glutaraldehyde modified allergen extracts in children and adults

M. Guzmán-Fulgencio, R. Caballero, B. Lara, M. Mena, M. Tejera, A. Sastre, J.-L. Subiza, E. Fernández-Caldas, M. Casanovas
Allergol Immunopathol (Madr) 2017;45:198-207